Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.75
0.47%
After-hours: Aug 15, 2025, 04:10 PM EDT
Inhibikase Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 73.44M | 56.49M | 913.42K | 3.09M | 2.35M | 9.17M | 14.86M | 1.91M | 3.96M | 7.19M | 5.78M | 32.21M | 36.61M | 40.75M | 44.85M | 46.84M | 9.61M |
Short-Term Investments | 19.74M | 41.05M | 2.33M | 4.85M | 7.4M | 4.09M | 1.97M | 19.03M | 21.76M | 15.86M | 20.75M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -363.62K | -534.75K | -565.17K | n/a | -43.09K | n/a | 1.61M | n/a | n/a | 2.78K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 79.6K | 64.52K | 39.88K | 13.84K | 6.55K | 47.98K | 110.14K | 217.48K | 586.58K | 332.77K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 425.23K | 923.13K | 1.12M | 932.42K | 919.05K | 565.3K | 107K | 264.38K | 958.78K | 712.67K |
Other Current Assets | 931.99K | 826.47K | 834.23K | 25K | 851.06K | 244.82K | 371.54K | 543.92K | 922.76K | 163.45K | 505.92K | 25K | 1.17M | 1.5M | 541.39K | 833.96K | 1.22M |
Total Current Assets | 94.16M | 98.45M | 4.19M | 8.6M | 10.81M | 14.21M | 17.55M | 21.98M | 27.63M | 24.37M | 27.99M | 33.95M | 38.39M | 42.47M | 45.87M | 49.22M | 11.87M |
Property-Plant & Equipment | 116.56K | 148.54K | 186.77K | 224K | 260.26K | 295.6K | 330.03K | 363.62K | 534.75K | 565.17K | 594.82K | 43.09K | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 116.56K | 148.54K | 186.77K | 224K | 260.26K | 295.6K | 330.03K | 363.62K | 534.75K | 565.17K | 594.82K | 43.09K | n/a | 1.61M | n/a | n/a | 2.78K |
Total Assets | 94.28M | 98.6M | 4.38M | 8.83M | 11.07M | 14.51M | 17.88M | 22.35M | 28.16M | 24.94M | 28.58M | 33.99M | 38.39M | 42.47M | 45.87M | 49.22M | 11.87M |
Account Payables | 1.69M | 943.02K | 2.53M | 1.34M | 1.29M | 646.77K | 734.56K | 754.15K | 959.08K | 1.15M | 781.22K | 860.44K | 806.2K | 1.09M | 553.8K | 897.23K | 715.02K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.68K | 23.68K | n/a | n/a | n/a | 142.62K | 1.25M |
Short-Term Debt | n/a | 110.52K | 71.66K | 152.22K | 280.61K | 381.78K | 149.03K | 147.97K | n/a | 145.84K | 142.05K | n/a | n/a | 248.91K | 248.91K | n/a | 994.79K |
Other Current Liabilities | 4.22M | 999.3K | 653.23K | 1.57M | 325.06K | 1.62M | 1.06M | 1.22M | n/a | 1.79M | 1.71M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 8.55M | 3.73M | 4.91M | 3.7M | 4.23M | 3.44M | 2.74M | 2.73M | 2.66M | 3.7M | 3.21M | 4.49M | 4.38M | 4.05M | 2.71M | 1.91M | 3.59M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 248.91K | 248.91K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | 25.61K | 58.33K | 90.12K | 121.01K | 149.97K | 178.11K | 205.45K | 232.02K | 3.63M | 806.2K | 2.72M | 1.91M | 248.91K | 248.91K |
Total Liabilities | 8.55M | 3.73M | 4.91M | 3.73M | 4.29M | 3.53M | 2.86M | 2.88M | 2.84M | 3.9M | 3.45M | 4.49M | 4.38M | 4.05M | 2.71M | 2.16M | 3.84M |
Total Debt | 74.77K | 110.52K | 145.21K | 177.83K | 209.49K | 622K | 270.04K | 297.94K | 325.01K | 351.29K | 374.07K | n/a | n/a | 248.91K | 248.91K | 248.91K | 1.24M |
Common Stock | 74.34K | 69.36K | 7.46K | 7.22K | 6.48K | 6.19K | 5.36K | 5.29K | 31.06K | 25.23K | 25.23K | 25.23K | 25.23K | 25.16K | 25.16K | 25.13K | 10.06K |
Retained Earnings | -108.1M | -94.42M | -82.29M | -76.51M | -71.55M | -66.9M | -62.72M | -58.13M | -52.35M | -47.87M | -43.59M | -39.1M | -34.46M | -29.82M | -24.78M | -20.3M | -17.67M |
Comprehensive Income | -967 | -37.25K | 1.75K | -1.02K | -1.8K | 877.00 | -143 | -1.71K | 165.82K | 104.72K | 26.83K | n/a | n/a | -0.00 | 0.00 | -0.00 | n/a |
Shareholders Equity | 85.73M | 94.87M | -530.59K | 5.1M | 6.78M | 10.98M | 15.02M | 19.46M | 25.32M | 21.04M | 25.14M | 29.5M | 34.01M | 38.42M | 43.16M | 47.05M | 8.04M |
Total Investments | 19.74M | 41.05M | 2.33M | 4.85M | 7.4M | 4.09M | 1.97M | 19.03M | 21.76M | 15.86M | 20.75M | n/a | n/a | n/a | n/a | n/a | n/a |